Design Therapeutics, Inc.
DSGN
$3.50
-$0.02-0.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.22% | 25.84% | 33.97% | 31.97% | 15.38% |
| Total Depreciation and Amortization | 11.07% | 10.99% | 11.85% | 15.18% | 21.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.39% | -2.23% | -31.07% | -39.43% | -34.70% |
| Change in Net Operating Assets | 114.10% | -236.40% | -273.15% | -254.34% | -166.76% |
| Cash from Operations | 11.42% | 26.39% | 24.34% | 15.26% | 5.87% |
| Capital Expenditure | 40.38% | -32.81% | 29.01% | 43.67% | 60.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.57% | -16.10% | 3.45% | 316.57% | 126.79% |
| Cash from Investing | -41.58% | -16.33% | 3.82% | 310.11% | 126.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -30.65% | -29.14% | 112.75% | 55.40% | 47.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -30.65% | -29.14% | 112.75% | 55.40% | 841.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,775.17% | 125.72% | 116.37% | 120.01% | 100.23% |